Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies
Clinical trial NCT03663712 · COMPLETED
Trial details
- NCT number
- NCT03663712
- Sponsor
- Dan Blazer III, M.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2022-10-13
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.